Pulmonx (LUNG) Invested Capital (2019 - 2025)

Pulmonx (LUNG) has 7 years of Invested Capital data on file, last reported at $91.0 million in Q4 2025.

• Invested Capital for Q4 2025 came in at $91.0 million, down 25.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $91.0 million (down 25.84% YoY), and the FY2025 annual result was $91.0 million, down 25.84% from the prior year.
• Invested Capital fell to $91.0 million in Q4 2025 per LUNG's latest filing, from $97.2 million in the prior quarter.
• Over five years, Invested Capital peaked at $233.5 million in Q1 2021 and troughed at $91.0 million in Q4 2025.
• A 5-year average of $162.5 million and a median of $166.9 million in 2022 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2021 and 2025: Invested Capital soared 220.32% in 2021, then decreased 25.92% in 2025.
• A 5-year view of Invested Capital shows it stood at $210.1 million in 2021, then slipped by 18.67% to $170.9 million in 2022, then dropped by 9.2% to $155.2 million in 2023, then slipped by 20.92% to $122.7 million in 2024, then slipped by 25.84% to $91.0 million in 2025.
• Business Quant data shows LUNG's Invested Capital at $91.0 million in Q4 2025, $97.2 million in Q3 2025, and $106.2 million in Q2 2025.